From The Hill: A consumer-level joint pain supplement has been recalled due to high levels of lead, the U.S. Food & Drug Administration announced Monday.
Handelnine Global Limited, doing business as Navafresh, has recalled two lots of its Rheumacare capsules after FDA testing revealed “higher than permissible levels” of lead were found in the product.
The recalled lots include CAM040 & CALO79-N. The product was distributed to consumers nationwide through www.navafresh.com.
“Sustained exposure of elevated levels of lead poses increased potential toxicological risks to consumers to include cognitive impairment, depression, nausea and abdominal pain, motor incoordination, and peripheral neuropathy (loss of muscle control),” according to the FDA.
View the complete details on this recall at: https://t.co/fqLH8qAvs9. pic.twitter.com/g5qyEayWdh
— U.S. FDA Recalls (@FDArecalls) December 22, 2025
Read more at The Hill
The Dennis Michael Lynch Podcast archive is available below, with the most recent on top. Never miss an episode. Subscribe to the show by downloading The DML News App or go to Apple Podcasts.
